about
High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.The role of narrow band imaging in the detection of recurrent laryngeal and hypopharyngeal cancer after curative radiotherapy.Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences.Nuclear presence of adhesion-/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin.A new strategy for the surgical management of RLN infiltrated by well-differentiated thyroid carcinoma.Baha implant as a hearing solution for single-sided deafness after retrosigmoid approach for the vestibular schwannoma: surgical results.Baha implant as a hearing solution for single-sided deafness after retrosigmoid approach for the vestibular schwannoma: audiological results.Marker profiling of normal keratinocytes identifies the stroma from squamous cell carcinoma of the oral cavity as a modulatory microenvironment in co-cultureRevision operations after previous stapes surgery for persisting hearing lossFine needle aspiration biopsy proves increased T-lymphocyte proliferation in tumor and decreased metastatic infiltration after treatment with doxorubicin bound to PHPMA copolymer carrierTargeted Polymer-Based Probes for Fluorescence Guided Visualization and Potential Surgery of EGFR-Positive Head-and-Neck Tumors
P50
Q33597525-B8BC31A7-D1A9-4B89-B28A-5D6F60C2AAF6Q33912104-EBD977C0-33E9-46F7-93F1-1B5EBCE6C237Q35201899-6E5821F0-F971-45DE-8F49-8B8C27BB6667Q37334966-07BAF417-0B6E-4A12-9980-A97B5BEE2122Q40004933-5F0DF472-7F5A-47EF-A30B-0767932A39DBQ40355995-B004145F-A362-4AF4-9A52-426A1BA4FC6CQ40556671-1EEFD970-A42E-4DFF-BFAC-0AE9450403D1Q50310488-C9A1AECB-F883-4B39-80A6-1A9724588D3EQ50348844-861DA27A-A5B8-4A00-B64E-BC3D4743B311Q57664423-8BB103F3-2738-4223-B591-B0789D9212E3Q58035388-0BE4F29E-D307-470D-A9CF-58007F7CB1F7Q86664254-32E4D4A8-BD16-46F9-857F-FAF496A35A5EQ92446249-0A655047-7949-4502-868E-F48D51A7241E
P50
description
otorinolaryngolog
@cs
researcher, ORCID id # 0000-0002-9233-6702
@en
wetenschapper
@nl
name
Jan Boucek
@ast
Jan Boucek
@es
Jan Boucek
@nl
Jan Bouček
@cs
Jan Bouček
@en
type
label
Jan Boucek
@ast
Jan Boucek
@es
Jan Boucek
@nl
Jan Bouček
@cs
Jan Bouček
@en
prefLabel
Jan Boucek
@ast
Jan Boucek
@es
Jan Boucek
@nl
Jan Bouček
@cs
Jan Bouček
@en
P214
P1153
22933828500
P214
P31
P496
0000-0002-9233-6702
P569
1976-09-07T00:00:00Z